There is a failure to thoroughly review the failure of a batch or any of its components to meet any of its specifications whether or not the batch has been already distributed.
Inspection Record
Lantheus Medical Imaging, Inc. — FDA 483 Findings
Inspectors Daniel L Zheng · Lori M NewmanThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Laboratory controls do not include the establishment of scientifically sound and appropriate sampling plans and test procedures designed to assure that components and drug product containers conform to appropriate standards of identity, strength, quality and purity.
Appropriate controls are not exercised over computers or related systems to assure that changes in master production and control records or other records are instituted only by authorized personnel.
Access to the storage area for labels and labeling materials is not limited to authorized personnel.
Component testing is deficient in that each component is not tested for conformity with all appropriate written specifications for purity, strength, and quality.
The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.
Strict control is not exercised over labeling issued for use in drug product labeling operations.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- SURETEC INNOVATIONS LLC2026-03-05 · US FDASimilar to finding 6 The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.
- BPI Labs, LLC2026-04-17 · US FDASimilar to finding 6 The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.
- Aurobindo Pharma Ltd. Telangana2019-05-24 · US FDASimilar to finding 6 The responsibilities and procedures applicable to the quality control unit are not in writing and fully followed.
- GH Genhelix, S.A.2022-01-25 · US FDASimilar to finding 6 The responsibilities and procedures applicable to the quality control are not in writing and fully followed.
- Baxter Healthcare Corporation2025-11-25 · US FDASimilar to finding 3 Appropriate controls are not exercised over computers or related systems to assure that changes in master production and control records or other records are…
A record as of the US FDA document published on 2026-10-23. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.